Chemistry and Chemical Engineering Alumnus Paul Himes Turns Curiosity Into a Career

Paul Himes 

Summers in a chemistry lab at Rose-Hulman Institute of Technology sparked an interest that led Paul Himes to a career ensuring the safety of drugs for conditions like diabetes, organ transplants, and lupus.

Himes, a 2012 chemistry and chemical engineering alumnus, was interested in the pharmaceutical industry when he was a third-year student at Rose-Hulman. Then he began his work in the lab of Professor Ross Weatherman, PhD.

Weatherman, who is head of the Rose-Hulman Department of Chemistry & Biochemistry, works with students to study treatments for breast cancer.

“I thought that was really the coolest thing ever,” said Himes. “I was actually making medicine. It was in a laboratory setting, but I knew these were real-world drugs, understanding how they’re made in the lab and how you can change those through different chemistries.”

He added chemistry as a second major. The rigorous scientific focus of Rose-Hulman’s engineering programs made pairing chemistry with his chemical engineering major a smooth process. Also helpful was the individualized guidance he received.

“At the time I chose Rose-Hulman, I thought I might get more one-on-one time,” Himes said. “And it was true. I was able to talk with professors…in a capacity that I don’t think I was going to be able to get at a larger campus.”

Today Himes is a principal scientist for Sanofi. Based in Framingham, Massachusetts, he oversees testing of treatments for complex, chronic, or rare diseases for the pharmaceutical company. He also holds a doctoral degree in pharmaceutical sciences from the University of North Carolina.

He credits his experiences collaborating with faculty and students at Rose-Hulman, working in the classroom and the lab to examine different ways of solving problems, for setting him on his current career path.

“We are all very curious minds at Rose-Hulman, and Rose-Hulman nurtures that curiosity,” Himes said. “It’s helped me a lot. If I think something is wrong, I want to know why, and the answer of ‘it’s always been this way’ is not good enough.”

 

Return to Top